# A 74-year-old man with COPD and BPH starting umeclidinium reports new difficulty starting urination and a sensation of incomplete bladder emptying. Which is the nurse's most appropriate action?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=en  
> language: en  
> subject: Medical Emergencies  
> category: PA

## Question

A 74-year-old man with COPD and BPH starting umeclidinium reports new difficulty starting urination and a sensation of incomplete bladder emptying. Which is the nurse's most appropriate action?

## Option

1. Notify the provider — anticholinergic effects from umeclidinium can worsen BPH-related urinary retention; alternative therapy may be needed **✔ Correct answer**
2. Hold the umeclidinium dose and monitor the client's ability to void over the next 24 hours before contacting the provider.
3. Encourage the client to restrict oral fluid intake to less than 1,000 mL per day to decrease urine production and relieve bladder pressure.
4. Reassure the client that difficulty voiding is a typical finding in benign prostatic hyperplasia and is not caused by umeclidinium.

**Correct answer: 1**

## Explanation

Correct (2): Long-acting antimuscarinics (umeclidinium, tiotropium, aclidinium, glycopyrronium) can worsen urinary retention in BPH via M3 receptor blockade on the bladder. Cautioned/contraindicated when severe BPH or pre-existing retention. Provider may switch to a LABA-only regimen or LABA/ICS. (1) Real adverse effect. (3) Fluid restriction harms COPD. (4) Discontinuing all therapy risks COPD exacerbation.

## In-depth explanation

Memory Tip LAMA + BPH = caution — anticholinergic relaxes detrusor and contracts internal sphincter, worsening retention. Screen BPH/glaucoma history before initiation.

## Clinical scenario

Scenario 74-year-old male with COPD and BPH on umeclidinium 62.5 mcg daily × 2 weeks. New urinary hesitancy, weak stream, sensation of incomplete emptying.

## Key concepts

- **LAMA cautions** — Narrow-angle glaucoma, BPH/urinary retention, severe milk protein allergy (for some DPI carriers).
- **Urinary retention** — Inability to empty bladder; worsened by anticholinergic medications in BPH.
- **Detrusor relaxation** — M3 blockade reduces bladder contractility, contributing to retention.

## Related questions

- [A nurse is caring for an alert adult client with type 1 diabetes who reports tremors, swea…](https://mymerci.kr/pages/nclex_q.php?qn_id=360524&lang=en)
- [A 68-year-old client with COPD is admitted with shortness of breath and SpO2 86% on room a…](https://mymerci.kr/pages/nclex_q.php?qn_id=362940&lang=en)
- [A 58-year-old client arrives at the emergency department with crushing substernal chest pa…](https://mymerci.kr/pages/nclex_q.php?qn_id=362976&lang=en)
- [A 72-year-old client is brought to the emergency department by family who report that the …](https://mymerci.kr/pages/nclex_q.php?qn_id=363003&lang=en)
- [A 79-year-old client is admitted from a long-term care facility with diarrhea, decreased o…](https://mymerci.kr/pages/nclex_q.php?qn_id=363089&lang=en)
- [A 76-year-old female with chronic heart failure and atrial fibrillation receives digoxin 0…](https://mymerci.kr/pages/nclex_q.php?qn_id=374883&lang=en)
- [A 70-year-old client on long-term digoxin therapy reports new yellow-green halos around li…](https://mymerci.kr/pages/nclex_q.php?qn_id=374884&lang=en)
- [A 58-year-old client with type 2 diabetes mellitus and migraine prophylaxis is taking prop…](https://mymerci.kr/pages/nclex_q.php?qn_id=374893&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=391779&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._